ESF0 Stock Overview
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Eurofins Scientific SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €57.18 |
| 52 Week High | €65.56 |
| 52 Week Low | €44.46 |
| Beta | 0.60 |
| 1 Month Change | -3.90% |
| 3 Month Change | 5.50% |
| 1 Year Change | -12.78% |
| 3 Year Change | -31.11% |
| 5 Year Change | 41.75% |
| Change since IPO | 5,398.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| ESF0 | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -3.2% | -1.7% | -1.2% |
| 1Y | -12.8% | -14.8% | 1.8% |
Return vs Industry: ESF0 exceeded the German Life Sciences industry which returned -14.8% over the past year.
Return vs Market: ESF0 underperformed the German Market which returned 1.8% over the past year.
Price Volatility
| ESF0 volatility | |
|---|---|
| ESF0 Average Weekly Movement | 5.7% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ESF0 has not had significant price volatility in the past 3 months.
Volatility Over Time: ESF0's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 61,798 | Gilles Martin | www.eurofins.com |
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics.
Eurofins Scientific SE Fundamentals Summary
| ESF0 fundamental statistics | |
|---|---|
| Market cap | €11.11b |
| Earnings (TTM) | €256.50m |
| Revenue (TTM) | €6.51b |
43.3x
P/E Ratio1.7x
P/S RatioIs ESF0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESF0 income statement (TTM) | |
|---|---|
| Revenue | €6.51b |
| Cost of Revenue | €5.14b |
| Gross Profit | €1.37b |
| Other Expenses | €1.12b |
| Earnings | €256.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 24, 2024
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 21.10% |
| Net Profit Margin | 3.94% |
| Debt/Equity Ratio | 65.2% |
How did ESF0 perform over the long term?
See historical performance and comparison